ThermoGenesis Holdings, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. The Company operates a device and clinical division.

Informational stock graphs above displayed with B2i.

For more detailed information about ThermoGenesis stock, please the Official Nasdaq Page.

For all investor-related questions, please contact us at

How may we help?